Concepedia

David Koller

DK

Statistics

Publications

5

Citations

107

H-Index

5

Active since

2017

Affiliations

The Ohio State University(Current)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Sheba Medical Center

Translational Therapeutics (United States)

Cancer Genetics (United States)

David Koller is an author at The Ohio State University specializing in oncology, tumor biology, and cancer research.

Top concepts

Publications per year

2017–2022

5

Publications

5

β-catenin S45F mutation results in apoptotic resistance

Danielle Braggio, Abeba Zewdu, Priya Londhe et al. · Oncogene · 2020 · 32 citations · Full text

, , +21

Autophagy inhibition overcomes sorafenib resistance in S45F‐mutated desmoid tumors

Danielle Braggio, David Koller, Feng Jin et al. · Cancer · 2019 · 23 citations · Full text

Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors

Danielle Braggio, Fernanda Costas Casal de Faria, David Koller et al. · PLoS ONE · 2022 · 19 citations · Full text

miR-133a function in the pathogenesis of dedifferentiated liposarcoma

Peter Y. Yu, Gonzalo Lopez, Danielle Braggio et al. · Cancer Cell International · 2018 · 17 citations · Full text

Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates

Gonzalo Lopez, Danielle Braggio, Abeba Zewdu et al. · PLoS ONE · 2017 · 16 citations · Full text

, , +16

1–5 of 5